Aurinia Pharmaceuticals Stock News

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis. Aurinia said fourth-quarter revenue totaled $23.4 million, which was down from revenue of $50.03 million year-over-year. The company reported a quarterly earnings loss of 25 cents per share, which was worse than the loss of 6 cents per share in the fourth quarter of 2020. "Despite unpredictable COVID realities, varying … Full story available on Benzinga.com

NEW YORK , Feb. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BP, ZOM, NIO, VEON, and AUPH. … Full story available on Benzinga.com

IntriCon IIN +37%. NeuroSense Therapeutics (NRSN) +28%. Aurinia Pharmaceuticals AUPH -29%. Lexicon Pharmaceuticals LXRX -24%.

The biotech's underwhelming revenue guidance for 2022 is causing some shareholders to throw in the towel today.

The biotech''s underwhelming revenue guidance for 2022 is causing some shareholders to throw in the towel today.

Despite beating Street forecasts with its Q4 2021 financials, Aurinia Pharmaceuticals (AUPH) has lost ~20% in the pre-market Monday after the commercial-stage biopharmaceutical…

Aurinia (AUPH) delivered earnings and revenue surprises of 3.85% and 4.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Aurinia Pharma press release (NASDAQ:AUPH): Q4 GAAP EPS of -$0.25 beats by $0.02.Revenue of $23.4M (-53.2% Y/Y) beats by $1.57M.

Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q4 2021 Results - Earnings Call Transcript

The biotech's underwhelming revenue guidance for 2022 is causing some shareholders to throw in the towel today.

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ: LXRX ) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (NASDAQ: PRAX ) is likely to report earnings for its fourth quarter. • Blackstone Secured (NYSE: BXSL ) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million. • Mersana Therapeutics (NASDAQ: MRSN ) is estimated to report earnings for its fourth quarter. • Partner Communications Co (NASDAQ: PTNR ) is expected to report earnings for its fourth quarter. • Daqo New Energy (NYSE: DQ ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million. • Easterly Government Props (NYSE: DEA ) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million. • Aurinia Pharmaceuticals (NASDAQ: AUPH ) is expected to report earnings for its fourth quarter. • Kosmos Energy (NYSE: KOS ) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.

Aurinia (AUPH) delivered earnings and revenue surprises of 3.85% and 4.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Aurinia Pharma (NASDAQ:AUPH) is scheduled to announce Q4 earnings results on Monday, February 28th, before market open.The consensus EPS Estimate is -$0.27 and the consensus…

Aurinia (AUPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.